OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures
Angela Oberhofer, Abel J. Bronkhorst, Carsten Uhlig, et al.
Diagnostics (2022) Vol. 12, Iss. 8, pp. 1834-1834
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Use of ctDNA in early breast cancer: analytical validity and clinical potential
François Panet, Andri Papakonstantinou, María Borrell, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12

New Perspectives on the Importance of Cell-Free DNA Biology
Abel J. Bronkhorst, Vida Ungerer, Angela Oberhofer, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2147-2147
Open Access | Times Cited: 39

Artificial intelligence and machine learning in cell-free-DNA-based diagnostics
WY Tsui, Spencer C. Ding, Peiyong Jiang, et al.
Genome Research (2025) Vol. 35, Iss. 1, pp. 1-19
Closed Access

Cell‐free epigenomes enhanced fragmentomics‐based model for early detection of lung cancer
Yadong Wang, Qiang Guo, Zhicheng Huang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access

Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology
Inga Medina Diaz, Annette Nocon, Stefanie AE Held, et al.
Diagnostics (2023) Vol. 13, Iss. 7, pp. 1288-1288
Open Access | Times Cited: 13

Characterization of Mitochondrial DNA Methylation of Alzheimer’s Disease in Plasma Cell-Free DNA
Binrong Ding, Xue-wei Zhang, Zhengqing Wan, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2351-2351
Open Access | Times Cited: 13

Cancer Bioenergetics and Tumor Microenvironments—Enhancing Chemotherapeutics and Targeting Resistant Niches through Nanosystems
Aisha Farhana, Abdullah Alsrhani, Yusuf S. Khan, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3836-3836
Open Access | Times Cited: 11

Precise Therapy Using the Selective Endogenous Encapsidation for Cellular Delivery Vector System
Vacis Tatarūnas, Ieva Čiapienė, Agnė Giedraitienė
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 292-292
Open Access | Times Cited: 3

Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer
Caterina Gianni, Michela Palleschi, Filippo Merloni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14197-14197
Open Access | Times Cited: 18

Artificial intelligence in biology and medicine, and radioprotection research: perspectives from Jerusalem
Yehoshua Socol, Ariella Richardson, Imene Garali-Zineddine, et al.
Frontiers in Artificial Intelligence (2024) Vol. 6
Open Access | Times Cited: 2

Prenatal cell-free DNA testing of women with pregnancy-associated cancer: a retrospective cross-sectional study
Catharina J. Heesterbeek, Vivianne C. G. Tjan‐Heijnen, Joosje H. Heimovaara, et al.
The Lancet Regional Health - Europe (2024) Vol. 45, pp. 101024-101024
Open Access | Times Cited: 2

What fraction of cellular DNA turnover becomes cfDNA?
Ron Sender, Elad Noor, Ron Milo, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 6

The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization
Abel J. Bronkhorst, Stefan Holdenrieder
Medizinische Genetik (2023) Vol. 35, Iss. 4, pp. 201-235
Open Access | Times Cited: 6

Cell-Free Nucleic Acids: Physico-Chemical Properties, Analytical Considerations, and Clinical Applications
Abel J. Bronkhorst, Stefan Holdenrieder
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2312-2312
Open Access | Times Cited: 3

A pocket companion to cell-free DNA (cfDNA) preanalytics
Abel J. Bronkhorst, Stefan Holdenrieder
Tumor Biology (2023) Vol. 46, Iss. s1, pp. S297-S308
Open Access | Times Cited: 3

Targeted DNA methylation from cell-free DNA using hybridization probe capture
David N. Buckley, Gerald Gooden, Kuan Feng, et al.
NAR Genomics and Bioinformatics (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 5

What fraction of cellular DNA turnover becomes cfDNA?
Ron Sender, Elad Noor, Ron Milo, et al.
(2024)
Open Access

What fraction of cellular DNA turnover becomes cfDNA?
Ron Sender, Elad Noor, Ron Milo, et al.
eLife (2024) Vol. 12
Open Access

The chronicles of inflammation: uncovering of distinct patterns of NET degradation products
Janina Schoen, Marco Muñoz-Becerra, Jasmin Knopf, et al.
Frontiers in Drug Discovery (2024) Vol. 4
Open Access

LINE-1 cfDNA Methylation as an Emerging Biomarker in Solid Cancers
Uğur Gezer, Emre Özgür, Ebru Esin Yörüker, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3725-3725
Open Access

Detection of Brain-Derived Cell-Free DNA in Plasma
Camilla Pellegrini, Francesco Ravaioli, Sara De Fanti, et al.
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2541-2541
Open Access

Cell-free placental DNA: What do we really know?
Natalie Yuen, Melanie Lemaire, Samantha L. Wilson
PLoS Genetics (2024) Vol. 20, Iss. 12, pp. e1011484-e1011484
Open Access

Systematic evaluation of methylation-based cell type deconvolution methods for plasma cell-free DNA
Tongyue Sun, Jinqi Yuan, Yacheng Zhu, et al.
Genome biology (2024) Vol. 25, Iss. 1
Open Access

Blood-Based Biomarkers for Bladder Cancer Diagnosis and Prognosis
Karin Birkenkamp‐Demtröder, Iver Nordentoft, Trine Strandgaard, et al.
(2024), pp. 393-413
Closed Access

Page 1 - Next Page

Scroll to top